• Je něco špatně v tomto záznamu ?

Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited

Sterba J, Dusek L, Demlova R, Valik D.

. 2006 ; 52 (4) : 692-700.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc07521897

Grantová podpora
NR8448 MZ0 CEP - Centrální evidence projektů

BACKGROUND: To evaluate the influence of pretreatment plasma folate concentrations on methotrexate exposure in children with acute lymphoblastic leukemia/non-Hodgkin lymphoma treated with high-dose methotrexate, we assessed time profiles of plasma homocysteine, folate, and vitamin B(12) concentrations in children treated with high-dose methotrexate with leucovorin rescue. METHODS: We analyzed 98 treatment courses. The study endpoints were to determine how methotrexate exposure is related to homocysteine accumulation and whether it is influenced by pretreatment plasma folate. RESULTS: Peak concentrations of homocysteine increased from the start of the intravenous infusion through cessation of methotrexate therapy up to time point t(42), when this trend was reversed by administration of folinic acid. The area under the curve (AUC) for plasma homocysteine showed decreasing course-to-course tendencies with a statistically significant decrease only between courses 1 and 2 (P 10 nmol/L. Correspondingly, in the courses with low initial folate, peak plasma concentrations of methotrexate were significantly higher than in courses with high precourse concentrations of plasma folate. CONCLUSION: Endogenous pretreatment plasma folate modulates the magnitude of the methotrexate effect, providing support for a "folate overrescue" concept.

000      
00000naa 2200000 a 4500
001      
bmc07521897
003      
CZ-PrNML
005      
20131002141540.0
008      
090422s2006 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Štěrba, Jaroslav, $d 1962- $7 mzk2004237310
245    10
$a Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited / $c Sterba J, Dusek L, Demlova R, Valik D.
314    __
$a Department of Pediatric Oncology, University Hospital, Brno, Czech Republic
520    9_
$a BACKGROUND: To evaluate the influence of pretreatment plasma folate concentrations on methotrexate exposure in children with acute lymphoblastic leukemia/non-Hodgkin lymphoma treated with high-dose methotrexate, we assessed time profiles of plasma homocysteine, folate, and vitamin B(12) concentrations in children treated with high-dose methotrexate with leucovorin rescue. METHODS: We analyzed 98 treatment courses. The study endpoints were to determine how methotrexate exposure is related to homocysteine accumulation and whether it is influenced by pretreatment plasma folate. RESULTS: Peak concentrations of homocysteine increased from the start of the intravenous infusion through cessation of methotrexate therapy up to time point t(42), when this trend was reversed by administration of folinic acid. The area under the curve (AUC) for plasma homocysteine showed decreasing course-to-course tendencies with a statistically significant decrease only between courses 1 and 2 (P <or=0.05), indicating decreased whole-body homocysteine accumulation in response to administration of consecutive methotrexate courses. Therapeutic courses with low initial folate concentrations (<or=10 nmol/L) gave significantly higher responses in homocysteine accumulation expressed both as (hcys)AUC(0-66 h) and the peak t(42) homocysteine concentrations than did courses with initial folate >10 nmol/L. Correspondingly, in the courses with low initial folate, peak plasma concentrations of methotrexate were significantly higher than in courses with high precourse concentrations of plasma folate. CONCLUSION: Endogenous pretreatment plasma folate modulates the magnitude of the methotrexate effect, providing support for a "folate overrescue" concept.
650    _2
$a mladiství $7 D000293
650    _2
$a antimetabolity antitumorózní $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D000964
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a kyselina listová $x krev $7 D005492
650    _2
$a homocystein $x krev $7 D006710
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a leukovorin $x terapeutické užití $7 D002955
650    _2
$a nehodgkinský lymfom $x farmakoterapie $x krev $7 D008228
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methotrexát $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D008727
650    _2
$a akutní lymfatická leukemie $x farmakoterapie $x krev $7 D054198
650    _2
$a vitamin B 12 $x krev $7 D014805
650    _2
$a vitamin B komplex $x terapeutické užití $7 D014803
650    _2
$a financování organizované $7 D005381
700    1_
$a Dušek, Ladislav, $d 1967- $7 mzk2003181727
700    1_
$a Demlová, Regina $7 xx0063726
700    1_
$a Valík, Dalibor $7 xx0061177
773    0_
$w MED00003485 $t Neurochemistry international $g Roč. 52, č. 4 (2006), s. 692-700 $x 0197-0186
910    __
$a ABA008 $b x $y 9
990    __
$a 20090312170439 $b ABA008
991    __
$a 20131002142057 $b ABA008
999    __
$a ok $b bmc $g 644986 $s 497902
BAS    __
$a 3
BMC    __
$a 2006 $b 52 $c 4 $d 692-700 $i 0197-0186 $m Neurochemistry international $x MED00003485
GRA    __
$a NR8448 $p MZ0
LZP    __
$a 2009-B1/vtme

Najít záznam

Citační ukazatele

Možnosti archivace